Factor VII deficiency is rare. It is an autosomal recessive inherited
disease with an estimated prevalence of 1/1,000,000. We report the case of a
newborn male from first-degree consanguineous parents admitted at 15 days of
life due to a hemorrhagic syndrome. Hemostasis tests showed low prothrombin
time (PT) and normal activated partial thromboplastin time (aPTT). A
coagulation panel revealed isolated factor VII deficiency. In this case, we
highlight the clinical, biological, and therapeutic aspects of this condition
during the neonatal period.
References
[1]
Regragui, W., et al. (1999) Congenital Factor VII Deficiency: A Case Report. Maroc Medical, 21, No. 3.
[2]
El Harim Lamdouar, L., et al. (1982) Congenital Factor VII Deficiency: Two Case Reports. Maghreb Medical, 14, 44-46.
[3]
Mariani, G., Konkle, B.A. and Ingerslev, J. (2006) Congenital Factor VII Deficiency: Therapy with Recombinant Activated Factor VII—A Critical Appraisal. Haemophilia, 12, 19-27. https://doi.org/10.1111/j.1365-2516.2006.01180.x
[4]
Di Minno, M.N., Dolce, A., Mariani, G. and STER Study Group (2013) Bleeding Symptoms at Disease Presentation and Prediction of Ensuing Bleeding in Inherited FVII Deficiency. Thrombosis Haemostasis, 109, 1051-1059.
https://doi.org/10.1160/TH12-10-0740
[5]
Giansily-Blaizot, M., Verdier, R., Biron-Adréani, C., Schved, J.F., Bertrand, M.A., Borg, J.Y., et al. (2004) Analysis of Biological Phenotypes from 42 Patients with Inherited Factor VII Deficiency: Can Biological Tests Predict the Bleeding Risk? Haematologica, 89, 704-709.
[6]
Guillain, M.C. (1988) Constitutional Deficiencies of Factors II, V, VII, or X. Elsevier SAS, Paris.
[7]
Napolitano, M., Siragusa, S. and Mariani, G. (2017) Factor VII Deficiency: Clinical Phenotype, Genotype and Therapy. Journal of Clinical Medicine, 6, 38.
https://doi.org/10.3390/jcm6040038
[8]
Yatim, A. (1993) Congenital Factor VII Deficiency. PhD Thesis, Faculty of Medicine and Pharmacy of Rabat, Rabat.
[9]
Giansily, M. and Schved, J.-F. (2000) Constitutional Factor VII Deficiencies. Hematology, 4, 266-271.
[10]
Goudemand, J., Caron, C., Dreyfus, M., et al. (2003) Standardization of Factor VII/Activated Factor VII Measurement in Plasma of Patients Treated with Recombinant Factor Activated VII. Blood Coagulation & Fibrinolysis, 14, 505-511.
https://doi.org/10.1097/00001721-200307000-00013
[11]
Monpoux, F., Chambost, H., Haouy, S., Benadiba, J. and Sirvent, N. (2010) Recombinant Activated Factor VII in Pediatrics: A Universal Hemostatic. Archives of Pediatrics, 17, 1210-1219. https://doi.org/10.1016/j.arcped.2010.05.018
[12]
Tafer, N., Julliac, B., Morel, N., et al. (2007) Subarachnoid Hemorrhage due to Aneurysm Rupture and Factor VII Deficiency: A Case Report. Annales Françaises d'Anesthésie et de Réanimation, 26, 356-358.
https://doi.org/10.1016/j.annfar.2006.12.007
[13]
Lee, W.S. and Park, Y.S. (2010) A Case of Intracranial Hemorrhage in a Neonate with Congenital Factor VII Deficiency: A Case Report. Korean Journal of Pediatrics, 53, 913-916. https://doi.org/10.3345/kjp.2010.53.10.913
